Document is current
Any future updates will be listed below
-
Authors
Sytsma, Brandon J.
Allain, Vincent
Bourke, Struan
Faizee, Fairuz
Fathi, Mohsen
Ferreira, Leonardo M. R.
Brewer, W. Jared
Li, Lian
Pan, Fong L.
Rothrock, Allison G.
Nyberg, William A.
Li, Zhongmei
Wilson, Leah H.
Berdeaux, Rebecca
Eyquem, Justin
Pawell, Ryan S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (7591022C00053, 75N91020C00030, CA125123, P30 DK063720)
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 3 February 2025
First Online: 17 February 2025
Declarations
:
: B.J.S., S.B., F.F., L.H.W., and R.S.P. are or were employed by and have an equity interest in Indee Labs. L.M.R.F., J.B., L.L., F.L.P. and J.E. are or were consultants to Indee Labs. R.S.P. is an investor in and a venture partner at both Pioneer Fund and Axial, which have a financial interest in Indee Labs. The Ferreira Lab received support from Indee Labs as a subaward from the National Institute of Diabetes and Digestive and Kidney Diseases (Grant No. 1R43DK133029-01). Indee Labs has a commercial interest in developing patents related to HydroporeTM (WO2016109864A1 & WO2019084624A1). M.F. and R.B. are or were employed by and have an equity interest in CellChorus. CellChorus received support from the National Center for Translational Sciences (R44TR005137) and the National Institute of General Medical Sciences (R44GM149106) of the National Institutes of Health and the National Science Foundation (NSF2229323). CellChorus has a commercial interest in developing the TIMING assay. J.E. is a compensated co-founder at Mnemo Therapeutics; owns stocks in Mnemo Therapeutics and Cytovia Therapeutics; is a compensated scientific advisor for Enterome, Treefrog Therapeutics and Resolution Therapeutics; and is a holder of patents pertaining to but not resulting from this work. The Eyquem Lab received research support from Cytovia Therapeutic, Mnemo Therapeutics, Takeda and Indee Labs as a subaward from the National Cancer Institute (Contract No. 7591022C00053). All other authors declare no competing interests.
